Metabolic dysfunction-associated steatohepatitis progresses from steatosis through fibrosis to hepatocellular carcinoma, and the question of what initiates the inflammatory stage has never been settled. This review argues for ferroptosis — iron-dependent cell death driven by lipid peroxidation — as the primary lytic event.
The proposed circuit is bidirectional and self-amplifying. Hepatocytes rupture by ferroptosis and release damage-associated molecular patterns, which activate myeloid cells and cytokine release; that inflammatory environment then triggers ferroptosis in Kupffer cells themselves, removing the population that would otherwise resolve it. The authors set out a four-gene transcriptomic signature (FABP4, CAPG, QSOX1 and FXN) mapping the transition from metabolic stress to structural remodelling.
Two elements connect to things clinicians already know. The polymorphisms that predict progression — PNPLA3, TM6SF2, MBOAT7 — are presented as priming this specific vulnerability, which would explain why they predict outcome rather than steatosis alone. And the review addresses the paradox of polyunsaturated fatty acids: physiologically protective as signalling molecules, they become the substrate for peroxidation once antioxidant defences fail. That is a caution against assuming a dietary fat is beneficial irrespective of the tissue's redox state.
None of this is actionable. It is the mechanistic framework within which the next generation of MASH drugs will be argued.
- No clinical application; this is a mechanistic review
- Note the proposed explanation for why PNPLA3, TM6SF2 and MBOAT7 predict progression
- The polyunsaturated fatty acid paradox argues against simple dietary fat messaging in advanced disease
- The four-gene signature is proposed, not validated for clinical use
- Existing MASH management — weight, metabolic control, alcohol — is unchanged
Why it matters
It links the genetic variants that predict progression to a specific, drug-targetable form of cell death.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.
Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for gastroenterology & hepatology, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free